Stallergenes Greer plc is a global biopharmaceutical company headquartered in London, specializing in the diagnosis and treatment of respiratory allergies through immunotherapy.
Stallergenes Greer plc is the parent company of GREER Laboratories, Inc. (registered office is in the U.S.) and Stallergenes S.A.S. (registered office in France).
